Cresset Asset Management’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.17M | Buy |
23,401
+17,824
| +320% | +$4.93M | 0.02% | 405 |
|
|
2026
Q1 | $1.65M | Buy |
5,577
+840
| +18% | +$250K | 0.01% | 613 |
|
|
2025
Q4 | $1.29M | Buy |
4,737
+655
| +16% | +$178K | 0.01% | 695 |
|
|
2025
Q3 | $1.1M | Buy |
4,082
+587
| +17% | +$160K | ﹤0.01% | 710 |
|
|
2025
Q2 | $963K | Sell |
3,495
-4,528
| -56% | -$1.23M | ﹤0.01% | 696 |
|
|
2025
Q1 | $2.13M | Sell |
8,023
-1,718
| -18% | -$424K | 0.01% | 522 |
|
|
2024
Q4 | $2.3M | Sell |
9,741
-18,414
| -65% | -$4.23M | 0.01% | 512 |
|
|
2024
Q3 | $6.21M | Sell |
28,155
-18,882
| -40% | -$3.91M | 0.02% | 400 |
|
|
2024
Q2 | $9.25M | Buy |
47,037
+20,879
| +80% | +$4.31M | 0.04% | 300 |
|
|
2024
Q1 | $5.63M | Buy |
26,158
+4,867
| +23% | +$1.02M | 0.03% | 362 |
|
|
2023
Q4 | $4.59M | Sell |
21,291
-2,588
| -11% | -$552K | 0.03% | 360 |
|
|
2023
Q3 | $4.78M | Buy |
23,879
+2,962
| +14% | +$589K | 0.02% | 349 |
|
|
2023
Q2 | $3.88M | Buy |
20,917
+16,912
| +422% | +$3.13M | ﹤0.01% | 475 |
|
|
2023
Q1 | $767K | Buy |
4,005
+160
| +4% | +$28.9K | 0.02% | 392 |
|
|
2022
Q4 | $406K | Sell |
3,845
-1,081
| -22% | -$188K | 0.01% | 460 |
|
|
2022
Q3 | $872K | Buy |
4,926
+1,411
| +40% | +$279K | 0.01% | 381 |
|
|
2022
Q2 | $717K | Sell |
3,515
-1,524
| -30% | -$323K | 0.01% | 454 |
|
|
2022
Q1 | $1.2M | Sell |
5,039
-111
| -2% | -$26.1K | 0.01% | 355 |
|
|
2021
Q4 | $1.19M | Sell |
5,150
-4,178
| -45% | -$919K | 0.01% | 402 |
|
|
2021
Q3 | $1.8M | Hold |
9,328
| – | – | 0.02% | 251 |
|
|
2021
Q2 | $1.98M | Buy |
9,328
+4,321
| +86% | +$912K | 0.03% | 205 |
|
|
2021
Q1 | $1.02M | Buy |
5,007
+882
| +21% | +$174K | 0.02% | 300 |
|
|
2020
Q4 | $755K | Sell |
4,125
-550
| -12% | -$93.5K | 0.01% | 302 |
|
|
2020
Q3 | $782K | Sell |
4,675
-1,435
| -23% | -$242K | 0.01% | 271 |
|
|
2020
Q2 | $993K | Sell |
6,110
-2,586
| -30% | -$464K | 0.02% | 212 |
|
|
2020
Q1 | $1.5M | Buy |
8,696
+701
| +9% | +$140K | 0.05% | 136 |
|
|
2019
Q4 | $1.62M | Buy |
7,995
+3,482
| +77% | +$714K | 0.04% | 154 |
|
|
2019
Q3 | $954K | Buy |
4,513
+396
| +10% | +$82.7K | 0.03% | 190 |
|
|
2019
Q2 | $799K | Sell |
4,117
-166
| -4% | -$30.6K | 0.02% | 202 |
|
|
2019
Q1 | $705K | Buy |
4,283
+414
| +11% | +$73.2K | 0.03% | 144 |
|
|
2018
Q4 | $730K | Buy |
+3,869
| New | +$714K | 0.04% | 94 |
|
Other funds holding CME
Cresset Asset Management's CME Position: Q2 2026 in Review
Cresset Asset Management increased its CME Group (CME) stake by 320% in Q2 2026, buying an estimated $4.93M and bringing the position to 23,401 shares worth $5.17M. The position accounts for 0.02% of the portfolio, ranked #405.
Cresset Asset Management first reported a position in CME in Q4 2018 and has held it in 31 quarters since. The position peaked at $9.25M in Q2 2024. 1,698 funds tracked by Wall St. Rank hold CME as of Q2 2026.
- Cresset Asset Management held 23,401 shares of CME Group worth $5.17M as of Q2 2026.
- Cresset Asset Management bought 17,824 CME Group shares in Q2 2026, an estimated $4.93M.
- CME Group made up 0.02% of Cresset Asset Management's portfolio in Q2 2026, its #405 holding.
- Cresset Asset Management first reported a position in CME Group in Q4 2018 and has held it in 31 quarters since.
- Cresset Asset Management's CME Group position peaked at $9.25M in Q2 2024.
- 1,698 funds tracked by Wall St. Rank held CME Group as of Q2 2026.
Based on Cresset Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.